A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age seven
暂无分享,去创建一个
T. Tsuzuki | Y. Okuno | Yukichi Tanaka | S. Kojima | H. Muramatsu | Yoshiyuki Takahashi | Akinari Hinoki | Manabu Wakamatsu | Taro Yoshida | M. Hamada | W. Sumida | H. Uchida | T. Tainaka | C. Shirota | Y. Gotoh | Rieko Taniguchi
[1] L. Ousager,et al. Hereditary leiomyomatosis and renal cell carcinoma: a case series and literature review , 2021, Orphanet Journal of Rare Diseases.
[2] I. Chirivella,et al. Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome in Spain: Clinical and Genetic Characterization , 2020, Cancers.
[3] A. Aguilar-Shea,et al. [Hereditary leiomyomatosis and renal cell cancer]. , 2020, Semergen.
[4] R. Kuiper,et al. Renal cell carcinoma in young FH mutation carriers: case series and review of the literature , 2019, Familial Cancer.
[5] D. Evans,et al. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals. , 2019, European urology oncology.
[6] H. Go,et al. Long-term response of metastatic hereditary leiomyomatosis and renal cell carcinoma syndrome associated renal cell carcinoma to bevacizumab plus erlotinib after temsirolimus and axitinib treatment failures , 2019, BMC Urology.
[7] T. Shimamura,et al. Comprehensive genetic analysis of donor cell derived leukemia with KMT2A rearrangement , 2018, Pediatric blood & cancer.
[8] C. Genestie,et al. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers , 2017, Clinical genetics.
[9] P. Humphrey,et al. The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.
[10] B. Ristau,et al. Abnormal Cystic Tumor in a Patient with Hereditary Leiomyomatosis and Renal Cell Cancer Syndrome: Evidence of a Precursor Lesion? , 2015, Case Reports in Urology.
[11] W. Linehan,et al. Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment , 2014, Familial Cancer.
[12] R. Srinivasan,et al. 2008 CLINICAL FEATURES AND MANAGEMENT OF HEREDITARY LEIOMYOMATOSIS AND RENAL CELL CANCER (HLRCC) , 2012 .
[13] L. Thomas,et al. Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinoma , 2011, Journal of Medical Genetics.
[14] Alison Martin,et al. Targeted inactivation of fh1 causes proliferative renal cyst development and activation of the hypoxia pathway. , 2007, Cancer cell.
[15] L. Aaltonen,et al. Increased risk of cancer in patients with fumarate hydratase germline mutation , 2005, Journal of Medical Genetics.
[16] I. Leigh,et al. Fumarate hydratase mutations and predisposition to cutaneous leiomyomas, uterine leiomyomas and renal cancer , 2005, The British journal of dermatology.
[17] N. Terada,et al. The natural history of simple renal cysts. , 2002, The Journal of urology.